Universe Pharmaceuticals Inc (UPC)
2.15
-0.02
(-0.92%)
USD |
NASDAQ |
May 03, 16:00
2.03
-0.12
(-5.58%)
After-Hours: 20:00
Universe Pharmaceuticals Total Liabilities (Quarterly): 13.75M for Sept. 30, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | 13.75M |
| March 31, 2023 | 23.24M |
| March 31, 2023 | 23.24M |
| September 30, 2022 | 13.10M |
| March 31, 2022 | 10.21M |
| March 31, 2022 | 10.21M |
| September 30, 2021 | 11.21M |
| Date | Value |
|---|---|
| March 31, 2021 | 16.58M |
| March 31, 2021 | 16.58M |
| September 30, 2020 | 8.001M |
| March 31, 2020 | 9.300M |
| March 31, 2020 | 9.300M |
| September 30, 2019 | 5.453M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
5.453M
Minimum
Sep 2019
23.24M
Maximum
Mar 2023
13.09M
Average
11.21M
Median
Sep 2021
Total Liabilities (Quarterly) Benchmarks
| Sinovac Biotech Ltd | 1.635B |
| CASI Pharmaceuticals Inc | 51.10M |
| Zai Lab Ltd | 240.18M |
| I-MAB | 126.23M |
| Gracell Biotechnologies Inc (DELISTED) | 36.85M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 53.29M |
| Shareholders Equity (Quarterly) | 39.53M |
| Debt to Equity Ratio | 0.1387 |
| Current Ratio | 2.676 |
| Net Debt Paydown Yield | -10.32% |